journal article·2026-06Open access

A mitochondria-targeted nanoantioxidant restores alveolar bone homeostasis in periodontitis by quenching ROS and suppressing the cGAS-STING pathway

Ning Huang, Lingyan Cao, Yue Xu, Lisha Pan, Ao Zheng, Xiao Wang, Xinquan Jiang

Abstract

Prolonged periodontal inflammation and progressive alveolar bone loss are typical manifestations of periodontitis. Antioxidative therapies targeting the central role of reactive oxygen species (ROS) have been explored, but lack of subcellular specificity limits efficacy. Mitochondria function as an upstream redox hub that drives oxidative stress, inflammatory responses, and alveolar bone resorption, making mitochondrial redox modulation a promising yet underexplored strategy for periodontitis therapy. Herein, we developed a mitochondria-targeted, redox-responsive nanocomposite (TC/pSeSe) that enables programmable redox modulation of the pathological periodontal microenvironment. The antioxidative core consists of a ROS-responsive diselenide-containing copolymer (pSeSe) capable of selenium release, while the triphenylphosphine/chitosan (TC) coating confers mitochondrial-targeted, controlled redox activity, mucosal retention and cationic antibacterial properties. With preferential mitochondrial localization, TC/pSeSe undergoes diselenide bond cleavage and selenium release under oxidative stress, thereby restoring mitochondrial redox homeostasis and attenuating downstream mitochondrial DNA (mtDNA)-cGAS-STING-mediated inflammatory signaling. Through combined ROS scavenging and selenium-mediated support, TC/pSeSe mitigates ferroptosis in a partially glutathione peroxidase 4 (GPX4)-dependent manner and restores osteogenic potential in bone marrow-derived stem cells. In parallel, TC/pSeSe exhibits antibacterial activity against periodontal pathogens through combined selenium and the cationic TC coating functionalities. In vivo , TC/pSeSe restored alveolar bone regeneration and attenuated periodontal inflammation. Collectively, this study proposes a mitochondria-centered redox modulation strategy, providing a comprehensive and promising therapeutic approach for periodontitis treatment. • A mitochondria-targeted redox-responsive nanocomposite was developed to modulate oxidative stress in periodontitis. • ROS-responsive diselenide bonds release selenium to attenuate oxidative stress and ferroptosis partially via GPX4. • A TC coating facilitates mitochondrial accumulation with controlled redox activity, antibacterial defense, and mucoadhesion.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Advanced Nanomaterials in Catalysis · Selenium in Biological Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. An umbrella review of the evidence linking oral health and systemic noncommunicable diseases10.1038/s41467-022-35337-8 ↗
2. Oral polymicrobial communities: assembly, function, and impact on diseases10.1016/j.chom.2023.02.009 ↗
3. Periodontitis: from microbial immune subversion to systemic inflammation10.1038/nri3785 ↗
4. Periodontitis: facts, fallacies and the future10.1111/prd.12221 ↗
5. Systemic antibiotics increase microbiota pathogenicity and oral bone loss10.1038/s41368-022-00212-1 ↗
6. The role of the host-Neutrophil biology
7. Crosstalk between oxidative stress, mitochondrial dysfunction, chromosome instability, and the activation of the cGAS-STING/IFN pathway in systemic sclerosis10.1016/j.arr.2025.102812 ↗
8. Mitochondrial Reactive Oxygen Species (ROS) and ROS-induced ROS release10.1152/physrev.00026.2013 ↗
9. Osteoporosis and periodontal diseases - an update on their association and mechanistic links10.1111/prd.12422 ↗
10. Selenium/tellurium containing polymer materials in nanobiotechnology10.1016/j.nantod.2015.11.004 ↗
11. Diselenide-bridged mesoporous silica-based nanoplatform with a triple ROS-scavenging effect for intracerebral hemorrhage treatment10.1021/acsami.4c08726 ↗
12. Plants and microbes assisted selenium nanoparticles: characterization and application10.1186/s12951-014-0028-6 ↗
13. Redox-responsive comparison of diselenide and disulfide core-cross-linked micelles for drug delivery application10.3390/pharmaceutics15041159 ↗
14. A self‐adaptive biomimetic periosteum employing nitric oxide release for augmenting angiogenesis in bone defect regeneration10.1002/adhm.202302153 ↗
15. The effect of selenium nanoparticles on the osteogenic differentiation of MC3T3-E1 cells10.3390/nano11020557 ↗
16. Ultrasound-driven selenium nanoparticles realize bone defect repair through activating selenoproteins to regulate PI3K/AKT signaling pathway10.1021/acsnano.4c18240 ↗
17. Rapid selenoprotein activation by selenium nanoparticles to suppresses osteoclastogenesis and pathological bone loss10.1002/adma.202401620 ↗
18. Recent advances in mitochondria-targeting theranostic agents
19. Mitochondria targeting drugs for neurodegenerative diseases-Design, mechanism and application10.1016/j.apsb.2022.03.001 ↗
20. Regulating chondro-bone metabolism for treatment of osteoarthritis via high-permeability micro/Nano hydrogel microspheres
21. Synthesis, characterization, and controlled release of selenium nanoparticles stabilized by chitosan of different molecular weights10.1016/j.carbpol.2015.07.065 ↗
22. Chitosan-based self-healing hydrogel dressing for wound healing10.1016/j.cis.2024.103267 ↗
23. Factors influencing the antibacterial activity of chitosan and chitosan modified by functionalization10.3390/ijms22147449 ↗
24. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery10.1016/j.biomaterials.2015.02.001 ↗
25. Dual Redox responsive assemblies formed from diselenide block copolymers10.1021/ja908124g ↗
26. Poly(urethane–carbonate)s from carbon dioxide10.1021/acs.macromol.7b00142 ↗
27. Selenium-containing nanoparticles synergistically enhance Pemetrexed&NK cell-based chemoimmunotherapy10.1016/j.biomaterials.2021.121321 ↗
28. Design of diselenide-bridged hyaluronic acid nano-antioxidant for efficient ROS scavenging to relieve colitis10.1021/acsnano.2c05558 ↗
29. Conventional diagnostic criteria for periodontal diseases (plaque-induced gingivitis and periodontitis)10.1111/prd.12579 ↗
30. The oral microbiota: dynamic communities and host interactions10.1038/s41579-018-0089-x ↗
31. Periodontitis-associated Fusobacterium nucleatum promotes ulcerative colitis by ferroptosis-mediated gut barrier disruption10.1038/s41522-025-00763-1 ↗
32. The signalling effects of photobiomodulation on osteoblast proliferation, maturation and differentiation: a review10.1007/s12015-021-10142-w ↗
33. The RANKL-OPG system in clinical periodontology10.1111/j.1600-051X.2011.01810.x ↗
34. RANK/RANKL/OPG signalization implication in periodontitis: new evidence from a RANK transgenic mouse model10.3389/fphys.2017.00338 ↗
35. Macrophages in periodontitis: a dynamic shift between tissue destruction and repair10.1016/j.jdsr.2022.10.002 ↗
36. Blocking ubiquitin-specific protease 7 induces ferroptosis in gastric cancer via targeting Stearoyl-CoA desaturase
37. Redox regulation: mechanisms, biology and therapeutic targets in diseases10.1038/s41392-024-02095-6 ↗
38. Palmitoylation of GPX4 via the targetable ZDHHC8 determines ferroptosis sensitivity and antitumor immunity10.1038/s43018-025-00937-y ↗
39. RSL3 drives ferroptosis through GPX4 inactivation and ROS production in colorectal cancer10.3389/fphar.2018.01371 ↗
40. Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances10.1038/s41392-025-02253-4 ↗
41. Regulation of cGAS-STING signalling and its diversity of cellular outcomes10.1038/s41577-024-01112-7 ↗
42. The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation10.1038/s41392-023-01624-z ↗
43. DNA sensing by the cGAS-STING pathway in health and disease10.1038/s41576-019-0151-1 ↗
44. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-Mediated mtDNA maintenance10.7150/thno.50905 ↗
45. From mitochondria to immune networks: new mesenchymal stem cell strategies to treat periodontitis10.1186/s13287-025-04619-5 ↗
46. Antimicrobial activity of selenium nanoparticles (SeNPs) against potentially pathogenic oral microorganisms: a scoping review10.3390/pharmaceutics15092253 ↗
47. Chitosan scaffolds: expanding horizons in biomedical applications10.1016/j.carbpol.2023.121394 ↗
48. Surface chemistry engineered selenium nanoparticles as bactericidal and immuno-modulating dual-functional agents for combating methicillin-resistant Staphylococcus aureus infection10.1016/j.drup.2024.101102 ↗
49. Mechanism of alveolar bone destruction in periodontitis—Periodontal bacteria and inflammation10.1016/j.jdsr.2021.09.005 ↗
50. 3D-printed tri-element-doped hydroxyapatite/polycaprolactone composite scaffolds with antibacterial potential for osteosarcoma therapy and bone regeneration
51. Ferroptosis in periodontitis: mechanisms, impacts, and systemic connections10.1038/s41420-025-02550-5 ↗
52. Ferroptosis: molecular mechanisms and health implications10.1038/s41422-020-00441-1 ↗
53. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke10.1016/j.cell.2019.03.032 ↗
54. BSA-stabilized selenium nanoparticles ameliorate intracerebral hemorrhage's-like pathology by inhibiting ferroptosis-mediated neurotoxicology via Nrf2/GPX4 axis activation10.1016/j.redox.2024.103268 ↗
55. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis10.1016/j.cell.2017.11.048 ↗
56. Tumor-and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis10.1186/s12951-019-0562-3 ↗
57. Mitochondria‐targeted nanoparticles in treatment of neurodegenerative diseases